期刊文献+

奥施康定治疗45例儿童重度癌痛临床疗效及安全性观察 被引量:12

Therapeutic effect and safety of oxycontin in the treatment of 45 pediatric cases with severe cancer pain
下载PDF
导出
摘要 目的:观察奥施康定治疗儿童癌痛临床疗效及安全性。方法:应用奥施康定治疗45例重度癌痛患儿,奥施康定初始剂量10mg/12h。每24h根据病情、镇痛效果进行剂量滴定一次,24h如疼痛分数下降不至3分以下(含3分),且每日突破性疼痛大于2次,则第二天加前1天剂量的25%-50%。结果:45例患者奥施康定用药最小剂量10mg/12h,最大剂量60mg/12h,中位数40mg/12h。治疗后疼痛控制总有效率为100%。主要不良反应为便秘、恶心、头昏、嗜睡、皮肤瘙痒,均为轻中度,无重度不良反应发生。结论:奥施康定对儿童癌痛镇痛效果好、毒副作用小、疗效确切、安全性高。 Objective: To observe the therapeutic effect and safety of Oxycontin in the treatment of 45 pediatric cases with severe cancer pain. Methods: 45 pediatric cases with severe cancer pain were treated with Oxycontin. Oxycontin was administered at an initial does of 10 mg /12 h,and titrated every 24 hours according to the pain control and the adverse reactions. The second day,if score of pain decreased no less than 3( including 3 scores) and breakthrough pains are greater than 2 times,the total daily Oxycontin dose were increased by 25% to 50% of the before dose. Results: Among the 45 pediatric cases with severe cancer pain,the maximum dose of oxycontin was 10 mg /12 h,the minimum was 60 mg /12 h and the media was 40 mg /12 h. Total pain relief rate was 100%. The main adverse reactions were constipation,nausea,dizziness,somnolence,itch of skin,which were mild or moderate adverse effects,no severe adverse effect. Conclusion: Oxycontin showed good therapeutic effect in the treatment of pediatric cases with severe cancer pain,with mild adverse reactions,and high clinical safety.
作者 陈佳权 赖琳
出处 《现代肿瘤医学》 CAS 2015年第15期2204-2205,共2页 Journal of Modern Oncology
关键词 奥施康定 儿童 癌痛 Oxycontin pediatric cancer pain
  • 相关文献

参考文献11

  • 1WHO. Medical nedd for opioid analgesics in WHO achieving bal- ance in national opioids control policy: Guide21 ines for assessment [ M]. Geneva : WHO ,2000:324.
  • 2Biancofiore G. Oxycodone controlled release in cancer pain manage- ment[ J ]. Ther Clin Risk Manag, 2006,2 ( 3 ) : 29 - 234.
  • 3Gallego AO, Baron MG, Arranz EE. Oxycodone: A pharmacological and clinical review[ J]. Clin Transl Oncol,2007,9 (5) :298 - 307.
  • 4Bruera E, Belzile M, Pimskin E, et al. Randomized, double - blind cross - over trial comparing safety and efficacy of oral controlled - release oxycodone with controlled - release morphine in patients with cancer pain[ J]. J Clin Oneol, 1998,16 (10) :3222 - 3223.
  • 5Jamison RN, Raymond SA, Slawsby EA. Opioid therapy for chronic noncancer back pain. A randomized prospective study [ J ]. Spine, 1998,23 (23) :591 - 2600.
  • 6张广华,李锦成.奥施康定用于慢性癌性中重度疼痛的疗效观察[J].中国肿瘤临床,2008,35(13):733-735. 被引量:37
  • 7万德森.临床肿瘤学[M].科学出版社,2000:116.
  • 8Mercadante S, Ferrera P, David F, et al. The use of high doses of oxycodone in anacute palliative care unit [ J ]. Am J Hosp Palliate Med,2011,28(4) :242 -244.
  • 9刘勇,谢斌,程宝智,王萍,汪涛,胡传朋,吕遐智.奥施康定治疗中重度癌痛临床观察[J].现代肿瘤医学,2009,17(7):1335-1337. 被引量:10
  • 10何世保,方国全,王义平.奥施康定治疗慢性癌痛的疗效观察[J].淮海医药,2014,32(1):7-9. 被引量:8

二级参考文献22

  • 1刘华,王蔚,郑垂志,邢雪花.癌症三阶梯止痛563例分析[J].中国肿瘤临床,2004,31(23):1346-1348. 被引量:79
  • 2刘振华,李卉,李彦,丁全福.盐酸羟考酮控释治疗中、重度疼痛研究进展[J].武警医学,2005,16(3):211-213. 被引量:20
  • 3李春燕,孙呈祥.奥施康定片镇痛效果的临床观察[J].现代肿瘤医学,2006,14(5):611-612. 被引量:18
  • 4张冠中,谢晓冬,刘大为.盐酸羟考酮控释片治疗晚期癌症疼痛的临床应用[J].中国肿瘤临床,2007,34(2):72-74. 被引量:25
  • 5Reid CM, Martin RM, Sterne JA, et al. Oxycodone for cancer - related pain : meta - analysis of randomized controlled trials[ J]. Arch Intern Med,2006,166 ( 8 ) :837 - 843.
  • 6Biancofiore G. Oxycodone controlled release in cancer pain management[J]. Ther Clin Risk Manag,2006,2 ( 3 ) :229 - 234.
  • 7Jamison RN, Raymond SA, Slawsby EA. Opioid therapy for chronic noncancer back pain : A randomized prospective study [ J ]. Spine, 1998,23(23) :2591 -2600.
  • 8Ackerman SJ, Mordin M, Reblando J, et al. Patient reported utilization patterns of fentanyl transdermal system and oxyeodone hydrochloride controlled - release among patients with chronic nonmalignant pain[J]. J Manag Care Pharm,2003,9(3) :223 -231.
  • 9狄伟文 程高升 游在英.芬太尼—利多卡因合剂用于手术后切口敷料镇痛临床观察[J].临床麻醉学杂志,2000,16(2):69-69.
  • 10Clohisy DR, Mantyh PW. Bone cancer pain[J]. Cancer,2003, 97 (3 Suppl): 866-873.

共引文献50

同被引文献122

引证文献12

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部